ABSTRACT
ABSTRACT Objective: To determine the incidence of congenital hypothyroidism (CH) over a 10-year period at the Reference Service in Neonatal Screening of the state of Rio Grande do Sul (RSNS-RS). Subjects and methods: Historical cohort study including all newborns screened for CH by the RSNS-RS from January 2008 until December 2017. Data of all newborns with neonatal TSH (neoTSH; heel prick test) values ≥ 9 mIU/L were collected. According to neoTSH values, the newborns were allocated into two groups: Group 1 (G1), comprising newborns with neoTSH ≥ 9 mIU/L and serum TSH (sTSH) < 10 mIU/L, and Group 2 (G2), comprising those with neoTSH ≥ 9 mIU/L and sTSH ≥ 10 mIU/L. Results: Of 1,043,565 newborns screened, 829 (0.08%) had neoTSH values ≥ 9 mIU/L. Of these, 284 (39.3%) had sTSH values < 10 mIU/L and were allocated to the G1 group, while 439 (60.7%) had sTSH ≥ 10 mIU/L and were allocated to the G2 group, and 106 (12.7%) were considered missing data. The overall incidence of CH was 42.1 per 100,000 newborns screened (95% confidence interval [CI] 38.5-45.7/100,000) or 1:2377 screened newborns. The sensibility and specificity of neoTSH ≥ 9 mIU/L were 97% and 11%; of neoTSH 12.6 mUI/L, 73% and 85% respectively. Conclusion: In this population, the incidence of permanent and transitory CH was 1:2377 screened newborns. The neoTSH cutoff value adopted during the study period showed excellent sensibility, which matters for a screening test.
ABSTRACT
É apresentado o problema de anomalias causadas pelo diabete na gestaçäo. Discute-se sua etiologia e citam-se as mais encontradas. Aborda-se o problema do diagnóstico durante a gestaçäo com o intuito de diminuir a incidência e a gravidade das mesmas. Expöem-se alguns aspectos relativos a prevençäo
Subject(s)
Pregnancy , Humans , Male , Female , Abnormalities, Multiple , Fetal Diseases/etiology , Pregnancy in Diabetics/complicationsABSTRACT
Analisam-se um grupo de pacientes com deficiência de hormônio do crescimento (DHC), incluidos no Programa do Hormônio do Crescimento do INAMPS-RS, do Hospital Materno Infantil Presidente Vargas (HMIPV). Estes pacientes submeteram-se ao tratamento com o hormônio do crescimento (HC) por um período médio de três e meio a quatro anos. Foram estudados a prevalência de sexo, etiologia e classificaçäo da DHC. Deste grupo inicial, doze crianças foram avaliadas separadamente, a fim de um estudo mais acurado das condiçöes de nascimento e do crescimento antes e após o tratamento com HC. Junta-se a estes dados uma revisäo da literatura